Who owns Mersana Therapeutics?
- CUSIP Number: 59045l106
Tip: Access positions for across all investors
Analyze quarterly positions in Mersana Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mersana Therapeutics stock
Who bought or sold Mersana Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EverSource Wealth Advisors | 11.00 | $318.000100 | -21% | Dec 2025 |
|
| North Star Investment Management | 6.00 | $174.000000 | 0% | Dec 2025 |
|
Who sold out of Mersana Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AQR Capital Management | Jun 2025 | 5.1M | $1.5M |
| Millennium Management | Jun 2025 | 2.1M | $619k |
| Two Sigma Advisers | Jun 2025 | 937k | $277k |
| Two Sigma Investments | Jun 2025 | 823k | $244k |
| FMR | Jun 2025 | 139k | $41k |
| Algert Coldiron Investors | Jun 2025 | 101k | $30k |
| Point72 Asia | Jun 2025 | 75k | $22k |
| Luminus Management | Sep 2025 | 50k | $388k |
| Citadel Advisors | Jun 2025 | 48k | $14k |
| CWM | Sep 2025 | 2.9k | $22k |
| Advisor Group Holdings | Sep 2025 | 2.5k | $725.000000 |
| IFP Advisors | Sep 2025 | 610.00 | $188.002000 |
| Royal Bank of Canada | Jun 2025 | 150.00 | $0 |